Zogenix adds $60 million equity to take lead to NDA and fund operations until 2013
20 September 2011
Nancy Faigen
Please Login to read the full article.
20 September 2011
Nancy Faigen
nancy.faigen@informausa.com
Please Login to read the full article.
RELATED CONTENT
NEWS
- Zogenix's long-acting hydrocodone meets chronic pain endpoint, ready for 2012 filing
- Zogenix, Battelle agree to work toward out-licensing needle-free injection platform
- Alkermes' PhII ALKS-5461: new mechanism, opiate receptor modulation, for refractory depression
- Zogenix seeks US FDA OK for single-entity hydrocodone in lucrative pain market
ANALYSIS
Other Informa Analysis
COMMENT
Other Informa Comment
EVENTS
Today
Continental Zara Hotel, Budapest, Hungary
Today
Radisson Blu Royal Hotel, Dublin
Today
Hotel Sofitel Hamburg Alter Wall
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
